Koc, E. R. Et Al. 2024. Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study. Clinical Rheumatology , vol.43, no.12 , 4025-4026.

Koc, E. R., Güllü, G., Saridas, F., Gluscevic, S., Coskun, B. N., Pehlivan, Y., ... Calikusu, F. Z.(2024). Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study. Clinical Rheumatology , vol.43, no.12, 4025-4026.

Koc, Emine Et Al. "Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study," Clinical Rheumatology , vol.43, no.12, 4025-4026, 2024

Koc, Emine R. Et Al. "Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study." Clinical Rheumatology , vol.43, no.12, pp.4025-4026, 2024

Koc, E. R. Et Al. (2024) . "Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study." Clinical Rheumatology , vol.43, no.12, pp.4025-4026.

@article{article, author={Emine Rabia Koc Et Al. }, title={Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study}, journal={Clinical Rheumatology}, year=2024, pages={4025-4026} }